What is the ASRS-v1.1 ADHD test?

The Adult ADHD Self-Report Scale (ASRS-v1.1) is an 18-item questionnaire developed by the World Health Organization for adult ADHD screening. Part A (6 items) is the validated screening tool: 4 or more items in the positive zone constitutes a positive screen for adult ADHD.

How do I score the ASRS v1.1 Part A?

For items 1-4, responses of 'Sometimes', 'Often', or 'Very Often' count as positive. For items 5-6, only 'Often' or 'Very Often' count as positive. Count the number of positive items: ≥4 of 6 = positive screen warranting comprehensive evaluation.

What does a positive ASRS Part A screen mean?

A positive screen (≥4 of 6 items in the shaded zone) indicates significant ADHD symptom burden and warrants comprehensive diagnostic evaluation — not automatic treatment. Diagnosis requires clinical interview, collateral history, functional impairment assessment, and exclusion of alternative diagnoses.

What are the symptoms of ADHD in adults?

Adult ADHD symptoms include: difficulty finishing tasks, poor organization, forgetting appointments and obligations, avoiding mentally demanding tasks, restlessness, and acting as if driven by a motor. Inattentive symptoms (items 1-4) often predominate over hyperactivity (items 5-6) in adults, especially women.

What are ADHD treatment options for adults?

First-line pharmacotherapy: stimulants (amphetamine salts, methylphenidate) with strong evidence for efficacy. Second-line: non-stimulants (atomoxetine, guanfacine ER, viloxazine ER). Behavioral treatments: CBT focused on organizational skills, time management, and emotion regulation complement medication and improve functional outcomes.

How does ADHD present differently in adults vs children?

Adults typically show less hyperactivity and more inattentive, executive dysfunction symptoms: chronic disorganization, time blindness, difficulty prioritizing tasks, emotional dysregulation, and poor working memory. Many adults developed coping strategies that partially masked hyperactivity symptoms.

Does having ADHD symptoms mean I have ADHD?

Not necessarily. Many conditions produce attention and concentration difficulties including anxiety disorders, depression, sleep disorders, thyroid dysfunction, and situational stress. DSM-5 ADHD diagnosis requires symptoms present before age 12, in multiple settings, causing functional impairment, and not better explained by another condition.

Yes. ADHD is significantly underdiagnosed in women, who more often present with inattentive rather than hyperactive symptoms, and have been historically underrepresented in ADHD research. Women with ADHD often receive diagnoses of anxiety or depression first before ADHD is recognized.

What is the ASRS sensitivity and specificity?

ASRS Part A has reported sensitivity of 68.7% and specificity of 99.5% for DSM-IV ADHD in clinical samples (Kessler et al., Psychol Med 2005). High specificity means a positive screen is quite reliable, though sensitivity means some ADHD cases may be missed with Part A alone.

How does ADHD relate to substance use disorders?

Adults with ADHD have 2-3× higher rates of substance use disorders. Stimulant treatment of ADHD in adolescents actually reduces the risk of developing later substance use disorders — not increases it, contrary to common concern. However, careful assessment of misuse risk before prescribing stimulants is still warranted.

What medications are used for adult ADHD?

FDA-approved options include: stimulants (amphetamine/dextroamphetamine: Adderall; lisdexamfetamine: Vyvanse; methylphenidate: Ritalin, Concerta) and non-stimulants (atomoxetine: Strattera; viloxazine: Qelbree; guanfacine ER: Intuniv). All require careful prescribing, monitoring, and consideration of cardiovascular risk.

How does ADHD affect daily functioning in adults?

Untreated adult ADHD is associated with significantly higher rates of: job instability and underemployment, motor vehicle accidents (2-4× higher), relationship difficulties, financial problems, and lower educational attainment. Treatment significantly improves these functional outcomes.

Online Medical Tools — ASRS v1.1

Printed on 9/4/2026

For informational purposes only. This is not medical advice.

Mental Health

ASRS v1.1

ASRS v1.1 Part A is a brief 6-question screening tool for adult ADHD symptom patterns. It is designed for first-line identification of individuals who may benefit from full diagnostic ADHD assessment.

Formula: Common positive screen when >=4 of 6 items cross item-specific thresholds (Q1-4: Sometimes/Often/Very often; Q5-6: Often/Very often).

Trouble wrapping up final details once challenging parts are done

Difficulty getting things in order for tasks requiring organization

Problems remembering appointments or obligations

Avoid or delay tasks requiring a lot of thought

Fidget or squirm when sitting for a long time

Feel overly active and compelled to do things

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Complete Part A (6 Screening Items)

The patient self-reports how often they experienced each of 6 symptoms over the past 6 months using a 5-point scale (Never/Rarely/Sometimes/Often/Very Often). Items cover inattention (Q1-4) and hyperactivity/impulsivity (Q5-6) domains.

Apply Item-Specific Threshold Shading

Each item has a threshold frequency that marks the 'shaded' (positive) zone: for Q1-4 the threshold is 'Sometimes' or higher; for Q5-6 the threshold is 'Often' or higher. Count how many items fall in the shaded zone.

Interpret: ≥4 of 6 = Positive Screen

If 4 or more of the 6 Part A items are in the shaded zone, the screen is positive and warrants comprehensive ADHD evaluation including clinical interview, collateral history, functional impairment assessment, and ruling out alternative explanations.

Who Uses the ASRS v1.1

Adult ADHD Screening in Primary Care

Primary Care Physicians

Adult ADHD is prevalent (2.5-5%) and frequently undiagnosed. ASRS-v1.1 provides a validated, standardized first-step screening tool for primary care providers before referring for comprehensive ADHD evaluation.

Psychiatry and Psychology Intake

Psychiatrists & Psychologists

At mental health intake, ASRS-v1.1 efficiently screens for ADHD as part of comprehensive assessment, especially when inattention, executive dysfunction, or emotional dysregulation are presenting complaints.

Employee Assistance Program Assessment

Occupational Health & EAP Counselors

Adults with undiagnosed ADHD have significantly higher rates of job instability, workplace accidents, and reduced productivity. EAP counselors use ASRS-v1.1 to identify ADHD as a contributing factor when workplace performance problems are reported.

College Disability Services Screening

College Disability Services Staff

Many adults receive their first ADHD diagnosis when academic demands increase in college. Disability services offices use ASRS-v1.1 to screen students seeking accommodations for attention and organizational difficulties.

ADHD Treatment Monitoring

Psychiatrists & Primary Care Physicians

ASRS-v1.1 can be used serially to monitor symptom burden in response to pharmacotherapy (stimulants, atomoxetine) and behavioral interventions over time, providing a standardized treatment outcome measure.

Pro Tips

ASRS Is a Screen — Diagnosis Requires Comprehensive Evaluation

A positive ASRS Part A does not diagnose ADHD. Diagnosis requires clinical interview establishing symptom severity, childhood onset (symptoms must have been present before age 12), functional impairment across multiple settings, and exclusion of alternative diagnoses (anxiety, mood disorders, sleep disorders, thyroid disease).

Adult ADHD Prevalence Is 2.5-5% — Often Diagnosed Late

Adult ADHD affects approximately 2.5-5% of adults, but many were not diagnosed in childhood, particularly women and those with predominantly inattentive presentations. Adults may have developed compensatory strategies that masked symptoms for decades before recognition.

Comorbidities Are the Rule, Not the Exception

Approximately 50% of adults with ADHD have comorbid anxiety disorders, 38% have depression, and 20% have bipolar disorder. These comorbidities must be identified and treated concurrently — treating ADHD alone without addressing comorbid depression often yields suboptimal outcomes.

ADHD Symptoms in Women Are Often Inattentive Not Hyperactive

Women with ADHD more frequently present with inattentive symptoms (forgetting, disorganization, difficulty completing tasks) rather than the hyperactive/impulsive presentation more common in men. This has historically led to significant underdiagnosis of ADHD in women and girls.

Stimulants Are Controlled Substances — Assess Misuse Risk

Stimulant medications (amphetamines, methylphenidate) are Schedule II controlled substances with misuse potential. Before prescribing, assess for substance use disorders and consider non-stimulant alternatives (atomoxetine, guanfacine, viloxazine) for high-risk patients.

Non-Stimulant Options Are Available

Non-stimulant medications include atomoxetine (SNRi, FDA-approved for adult ADHD), guanfacine ER (alpha-2 agonist), and viloxazine ER (norepinephrine reuptake inhibitor). Onset is slower (2-4 weeks) than stimulants but they are non-scheduled and appropriate when stimulant misuse is a concern.

CBT and Organizational Coaching Augment Medication

Cognitive behavioral therapy (CBT) focused on ADHD-specific skill-building (task management, time estimation, emotion regulation) significantly improves functional outcomes when combined with pharmacotherapy versus medication alone.

ADHD Is a Neurodevelopmental Condition — Not a Lifestyle Issue

DSM-5 requires symptoms to have been present before age 12 and to cause impairment in two or more settings (work, home, social). Adult patients often describe 'always being this way' — this developmental history is a critical diagnostic requirement distinguishing ADHD from acquired attention difficulties.

ADHD Is Associated With Higher Rates of Substance Use Disorders

Adults with ADHD have approximately 2-3× higher rates of substance use disorders compared to the general population. Paradoxically, treating ADHD with stimulants reduces the risk of developing substance use disorders in adolescents and adults, contrary to common concerns.

Anxiety and Depression Can Mimic ADHD on ASRS

Anxiety (worry, distraction), depression (concentration problems, low motivation), bipolar disorder (racing thoughts, impulsivity), and sleep disorders (inattention from fatigue) can all produce positive ASRS screens without true ADHD. Clinical differentiation is essential before starting ADHD-specific treatment.

Common Questions About Your Results

Evidence-Based Methodology

ASRS-v1.1 developed by Kessler et al. (Psychol Med 2005) for WHO Adult ADHD Initiative. Part A sensitivity 68.7%, specificity 99.5% for DSM-IV ADHD in a clinical sample. Validated in multiple populations including primary care and general population. CHADD and AHRQ recommend structured screening for adult ADHD using ASRS. Adult ADHD prevalence meta-analysis: Simon et al. (Eur Psychiatry 2009) — 2.5% worldwide. Faraone et al. (Nat Rev Dis Primers 2021) reviewed adult ADHD epidemiology and management.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

A positive ASRS Part A pattern suggests elevated adult ADHD symptom burden and supports formal clinical ADHD assessment.

When to Use This Tool

Use in adult behavioral-health or primary-care intake when inattention/executive symptoms are reported.

Limitations

ASRS is self-reported and screening-oriented. It does not establish diagnosis, childhood-onset history, or functional pervasiveness across settings on its own.

For related assessments, see PHQ-9, GAD-7 and MDI Depression Scale.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools